Invention Grant
- Patent Title: Signatures and determinants for diagnosing infections and methods of use thereof
-
Application No.: US14377887Application Date: 2013-02-08
-
Publication No.: US09726668B2Publication Date: 2017-08-08
- Inventor: Kfir Oved , Eran Eden , Ilan Ifergan
- Applicant: MeMed Diagnostics Ltd.
- Applicant Address: IL Tirat HaCarmel
- Assignee: MeMed Diagnostics Ltd.
- Current Assignee: MeMed Diagnostics Ltd.
- Current Assignee Address: IL Tirat HaCarmel
- International Application: PCT/EP2013/052619 WO 20130208
- International Announcement: WO2013/117746 WO 20130815
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/574 ; A61K39/00 ; C12N15/115 ; A61K39/395 ; G01N33/569 ; G01N33/68 ; G01N27/447

Abstract:
Antibiotics (Abx) are the world's most misused drugs. Antibiotics misuse occurs when the drug is administered in case of a non-bacterial infection (such as a viral infection) for which it is ineffective. Overall, it is estimated that 40-70% of the worldwide Abx courses are mis-prescribed. The financial and health consequences of Abx over-prescription include the direct cost of the drugs, as well as the indirect costs of their side effects, which are estimated at >$15 billion annually. Furthermore, over-prescription directly causes the emergence of Abx-resistant strains of bacteria, which are recognized as one of the major threats to public health today. This generates an immediate need for reliable diagnostics to assist physicians in correct Abx prescription, especially at the point-of-care (POC) where most Abx are prescribed. Accordingly, some aspects of the present invention provide methods using biomarkers for rapidly detecting the source of infection and administrating the appropriate treatment.
Public/Granted literature
- US20150017630A1 SIGNATURES AND DETERMINANTS FOR DIAGNOSING INFECTIONS AND METHODS OF USE THEREOF Public/Granted day:2015-01-15
Information query